|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Osiris Therapeutics, Inc. (OSIR) |
|
|
$18.99 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
34,453,000 |
| Market
Cap: |
654.26(M) |
| Last
Volume: |
115,569 |
Avg
Vol: |
53,611 |
| 52
Week Range: |
$18.99 - $18.99 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Neumayer Matthew Paul |
Principal Accounting Officer |
• – – |
2014-05-27 |
4 |
OE |
$5.08 |
$26,079 |
D/D |
3,750 |
6,750 |
|
- |
|
| Jacoby Philip R Jr |
Chief Financial Officer |
• – – |
2014-05-21 |
4 |
S |
$15.43 |
$245,998 |
D/D |
(15,947) |
12,500 |
|
- |
|
| Jacoby Philip R Jr |
Chief Financial Officer |
• – – |
2014-05-21 |
4 |
OE |
$5.08 |
$117,166 |
D/D |
15,947 |
28,447 |
|
- |
|
| Williams Michelle Leroux |
Chief Scientific Officer |
• – – |
2014-03-14 |
4 |
S |
$13.91 |
$166,009 |
D/D |
(11,934) |
0 |
|
- |
|
| Williams Michelle Leroux |
Chief Scientific Officer |
• – – |
2014-03-14 |
4 |
OE |
$12.01 |
$143,327 |
D/D |
11,934 |
11,934 |
|
- |
|
| Williams Michelle Leroux |
Chief Scientific Officer |
• – – |
2014-03-13 |
4 |
S |
$14.14 |
$706,925 |
D/D |
(50,000) |
0 |
|
- |
|
| Williams Michelle Leroux |
Chief Scientific Officer |
• – – |
2014-03-13 |
4 |
OE |
$5.08 |
$358,938 |
D/D |
50,000 |
50,000 |
|
- |
|
| Klingemann Hans-Georg |
Director |
– • – |
2014-02-06 |
4 |
A |
$14.93 |
$74,650 |
D/D |
5,000 |
6,250 |
|
- |
|
| Friedli Peter |
Chairman |
– • • |
2014-02-06 |
4 |
A |
$14.93 |
$149,300 |
D/D |
10,000 |
10,204,404 |
|
- |
|
| Gutzwiller Felix |
Director |
– • – |
2014-02-06 |
4 |
A |
$14.93 |
$104,510 |
D/D |
7,000 |
84,500 |
|
- |
|
| Friedli Peter |
Chairman |
– • • |
2014-01-17 |
4 |
A |
$0.00 |
$0 |
I/I |
0 |
4,606,051 |
|
- |
|
| Jacoby Philip R Jr |
Chief Financial Officer |
• – – |
2013-11-25 |
4 |
S |
$15.99 |
$293,680 |
D/D |
(18,372) |
12,500 |
|
- |
|
| Jacoby Philip R Jr |
Chief Financial Officer |
• – – |
2013-11-25 |
4 |
OE |
$5.08 |
$25,395 |
D/D |
4,999 |
30,872 |
|
- |
|
| Jacoby Philip R Jr |
Chief Financial Officer |
• – – |
2013-11-25 |
4 |
OE |
$6.46 |
$92,838 |
D/D |
13,373 |
25,873 |
|
- |
|
| Williams Michelle Leroux |
Chief Scientific Officer |
• – – |
2013-11-15 |
4 |
S |
$15.50 |
$379,632 |
D/D |
(24,500) |
0 |
|
- |
|
| Williams Michelle Leroux |
Chief Scientific Officer |
• – – |
2013-11-15 |
4 |
OE |
$0.40 |
$77,975 |
D/D |
24,500 |
24,500 |
|
- |
|
| Neumayer Matthew Paul |
Principal Accounting Officer |
• – – |
2013-08-20 |
4 |
S |
$19.75 |
$224,656 |
D/D |
(11,375) |
0 |
|
- |
|
| Neumayer Matthew Paul |
Principal Accounting Officer |
• – – |
2013-08-20 |
4 |
OE |
$5.08 |
$118,615 |
D/D |
11,375 |
11,375 |
|
- |
|
| Friedli Peter |
Chairman |
– • • |
2013-08-14 |
4 |
D |
$25.44 |
$11,000,002 |
D/D |
(432,390) |
10,194,404 |
|
- |
|
| Friedli Peter |
Chairman |
– • • |
2013-08-14 |
4 |
OE |
$11.00 |
$11,000,000 |
D/D |
1,000,000 |
10,626,794 |
|
- |
|
| Gutzwiller Felix |
Director |
– • – |
2013-02-12 |
4 |
A |
$7.73 |
$54,110 |
D/D |
7,000 |
77,500 |
|
- |
|
| Moyes Jay M |
Director |
– • – |
2013-02-12 |
4 |
A |
$7.73 |
$38,650 |
D/D |
5,000 |
21,500 |
|
- |
|
| Friedli Peter |
Chairman |
– • • |
2013-02-12 |
4 |
A |
$7.73 |
$77,300 |
D/D |
10,000 |
9,626,794 |
|
- |
|
| Klingemann Hans-Georg |
Director |
– • – |
2013-02-12 |
4 |
A |
$7.73 |
$9,663 |
D/D |
1,250 |
1,250 |
|
- |
|
| Moyes Jay M |
Director |
– • – |
2013-02-06 |
4 |
A |
$14.93 |
$74,650 |
D/D |
5,000 |
26,500 |
|
- |
|
131 Records found
|
|
Page 2 of 6 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
